Cancer Risk Panel - Comprehensive

Service Description

A broad biomarker assessment including tumour markers, gastric health markers, and gender-specific cancer markers. Includes all markers from Basic and Advanced panels. Core Biomarkers: - Cancer Antigen 19-9 (CA 19-9) - Alpha-Fetoprotein (AFP) - Carcinoembryonic Antigen (CEA) - Cytokeratin-19 Fragment (CYFRA 21-1) - Neuron-Specific Enolase (NSE) - Cancer Antigen 242 - Cancer Antigen 72-4 - Ferritin - β2-Microglobulin Gastric Condition Markers: -- Helicobacter pylori Antibody -- Pepsinogen I -- Pepsinogen II -- Cancer Antigen 242 (CA 242) Women-Specific Markers: - CA 15-3 (breast) - CA 125 (ovarian) Men-Specific Markers: - Total PSA (prostate) - Free PSA - PSA Ratio - hCG + β (testicular) Helps assess risk associated with: • Pancreatic cancer • Liver cancer • Lung cancer • Colorectal cancer • Neuroendocrine tumour • Gastric cancer • Multiple myeloma • Lymphoma and other malignancies • Breast cancer (Women only) • Ovarian cancer (Women only) • Prostate cancer (Men only) • Testicular cancer (Men only) Sample: BLOOD Results: 3 Days Phlebotomy fee: Included Note: Tumour markers are not diagnostic for cancer on their own. Elevated levels may also occur in non-cancerous conditions. Results should always be interpreted alongside clinical findings and appropriate imaging or diagnostic tests.